Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia.
Saved in:
| Title: | Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia. |
|---|---|
| Authors: | Levis MJ; Division of Hematologic Malignancies and Bone Marrow Transplant, Department of Oncology, Johns Hopkins University, Baltimore, MD., Hamadani M; Division of Hematology and Oncology, Department of Medicine, Center for International Blood and Marrow Transplant Research/Medical College of Wisconsin, Milwaukee, WI., Logan BR; Division of Hematology and Oncology, Department of Medicine, Center for International Blood and Marrow Transplant Research/Medical College of Wisconsin, Milwaukee, WI., Jones RJ; Division of Hematologic Malignancies and Bone Marrow Transplant, Department of Oncology, Johns Hopkins University, Baltimore, MD., Singh AK; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas, Kansas City, KS., Litzow MR; Division of Hematology and Transplant Center, Mayo Clinic, Rochester, MN., Wingard JR; Department of Medicine, University of Florida, Gainesville, FL., Papadopoulos EB; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Perl AE; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA., Soiffer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Ustun C; Division of Hematology Oncology and Cell Therapy, Rush University Medical Center, Chicago, IL., Oshima MU; Cancer Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Uy GL; Department of Medicine, Washington University, St. Louis, MO., Waller EK; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA., Vasu S; Division of Hematology, The Ohio State University, Columbus, OH., Solh M; Bone Marrow Transplant, Acute Leukemia, and Immunotherapy Program, Northside Hospital Cancer Institute, Atlanta, GA., Mishra A; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Muffly LS; Division of Blood and Marrow Transplantation, Stanford University, Stanford, CA., Kim HJ; Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Stelljes M; Department of Medicine/Hematology and Oncology, University of Münster, Münster, Germany., Najima Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan., Onozawa M; Department of Hematology, Hokkaido University Hospital, Sapporo, Japan., Thomson K; Department of Hematology, University College Hospital, London, United Kingdom., Chen C; Astellas Pharma Global Development, Inc, Northbrook, IL., Hasabou N; Astellas Pharma Global Development, Inc, Northbrook, IL., Rosales M; Astellas Pharma Global Development, Inc, Northbrook, IL., Hill JE; Astellas Pharma Global Development, Inc, Northbrook, IL., Gill SC; Astellas Pharma Global Development, Inc, Northbrook, IL., Nuthethi R; Astellas Pharma Global Development, Inc, Northbrook, IL., King D; The Emmes Company, Rockville, MD., Mendizabal A; The Emmes Company, Rockville, MD., Devine SM; National Marrow Donor Program, Minneapolis, MN., Horowitz MM; Division of Hematology and Oncology, Department of Medicine, Center for International Blood and Marrow Transplant Research/Medical College of Wisconsin, Milwaukee, WI., Chen YB; Department of Hematology/Oncology, Massachusetts General Hospital, Boston, MA. |
| Source: | Blood advances [Blood Adv] 2025 Oct 28; Vol. 9 (20), pp. 5123-5133. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
